Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 17, 2020

SELL
$2.16 - $5.41 $40,119 - $100,485
-18,574 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$1.53 - $4.53 $28,418 - $84,140
18,574 New
18,574 $64,000
Q3 2019

Nov 14, 2019

SELL
$1.95 - $3.93 $24,343 - $49,062
-12,484 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$3.45 - $26.86 $43,069 - $335,320
12,484 New
12,484 $49,000

Others Institutions Holding ACER

# of Institutions
1
Shares Held
365
Call Options Held
0
Put Options Held
0

About Acer Therapeutics Inc.


  • Ticker ACER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,100,000
  • Description
  • Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...
More about ACER
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.